Healthcare CMO Market, By Service (Medical Device Contract Manufacturing Services, Pharmaceutical Manufacturing Services), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Healthcare CMO Market was valued at US$ 509.6 Million in 2024 and is projected to grow at a CAGR of 13.60%to reach US$ 1629.8 Million by 2034.

CMOs (Contract Manufacturing Organizations) offer services in biotechnology and pharmaceutical industries by allowing them to focus on their business growth without allocating their time and other aspects of manufacturing.

Presence of major key players in CMOs has contributed in target market growth. Growing outsourcing manufacturing activities to CMOs to save time and money has further facilitated the target market growth. Growing prevalence of diseases, rising demand for drugs, Vaccines and medical devices, growing huge investment in research and development activities is expected to fruitful the demand for Healthcare CMO Market growth in future.

Rising demand for CMOs from emerging pharmaceutical and biotech companies has boosted the target market's growth. Further, outsourcing provides advantages such as a reduction in investment risks, expert knowledge, advance tools and technology, increasing productivity and efficiency, reducing labor work, and ideal for startups and small businesses which in turn has   facilitated the Healthcare CMO market growth.

 For instance, in May 2020, Pfizer Inc., has set to outsource its some part of drug production to remain its focus on coronavirus vaccines. Pfizer tapped its network of 200 outside contractors such as, Lonza Group, Catalent Inc., to play huge role in developing its existing medicines.

Acquisitions and adoption of strategic partnerships to fuel market growth

Presence of key players in market are focused on expanding their business growth through acquisitions and strategic partnerships which has led to fuel the demand for Healthcare CMO market growth.

For instance, in January 2023, Charles River Laboratories International Inc. announced a viral vector CDMO partnership with Rznomics Inc. for initiating the development of RNA-based anticancer gene therapy in liver cancer patients. This partnership will offer a stepping stone for Charles River to solidify its foothold in the global CDMO space.

For instance, in October 2021, (India) PAG leading Asia’s firm invested $145 million for acquisition of Acme Formulation Pvt. Ltd., a CDMO (Contract Development and Manufacturing Organization) firm which produce complex pharmaceutical products.

Restrains:

Some challenges faced by CMOs, are cost pressure, fierce competition, consolidation, and constant technological innovations, which hamper the market growth. The wrong innovative CMO solution provider may lead to a bad customer experience and variations in the standards of customer service may lead to quality problems. Further, it may also may lead to less control over the production process, which act as a challenges and disadvantages of CMOs which in turn restrained the Healthcare CMO market growth.

Healthcare CMO Market is segmented based on Service and Region.

Service Insight

On the basis of Service, Healthcare CMO Market is segmented into Medical Device Contract Manufacturing Services, Pharmaceutical Contract Manufacturing Market. Pharmaceutical Manufacturing Services is expected to dominate the target market growth due to huge investment in research and development activities by pharmaceutical companies because of growing prevalence of diseases.

For instance, in July 2022, Lonza planned to spend $518 million on a large-scale fill-finish manufacturing plant in Stein, Switzerland. A new manufacturing plant is expected to be completed in 2026. This plant will offer integrated, end-to-end CDMO services with expansion of drug production manufacturing plant.

Regional Insights:

On region the Healthcare CMO Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period due to continuous technological advancement, growing acquisitions of companies, robust healthcare infrastructure and increasing demand for medical devices.

Asia Pacific shows highest growing rate due to growing economic status, emerging pharmaceutical companies, favorable government policies and rising adoption of novel technologies is anticipated to increase demand for Healthcare CMO in the region.

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Million & CAGR from 2024 to 2034
Market Segmentation	By Service - Medical Device Contract Manufacturing Services, Pharmaceutical Manufacturing Services
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Healthcare CMO Market report based on Service and Region:

Healthcare CMO Market, By Service:

• Medical Device Contract Manufacturing Services
• Pharmaceutical Manufacturing Services

Healthcare CMO Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Healthcare CMO Market includes, Catalent Inc., Lonza Group, Boerhinger Ingelheim GmbH, Patheon Inc., Accellent Inc., Emergent Biosolutions Inc., Greatbatch Inc., Piramal Healthcare, Symbiosis Pharmaceutical Services, Cytovance Biologics, and others.

Recent Development:

• In March 2023, AGC Pharma Chemicals, CDMO (Contract Development and Manufacturing Organization) company announced strategic partnership with award winning CRO (Clinical Research Organization) CatSci for providing end to end non-clinical development of new therapeutics to serve customers across globe.
• In March 2023, Laxxon Medical partnered with Hovione an international pharmaceutical contract manufacturer for production of first 3D screen printed clinical samples of tablets with cGMP standards at industrial scale.
• In December 2022, AstraZeneca announced its strategic partnership with G42 Healthcare for expansion of pharmaceutical manufacturing in Abu Dhabi. This strategic agreement will provide innovation & sustainability, research and development activities and to localize innovative industries.

• Catalent Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Lonza Group
• Boerhinger Ingelheim GmbH
• Patheon Inc.
• Accellent Inc.
• Emergent Biosolutions Inc.
• Greatbatch Inc.
• Piramal Healthcare
• Symbiosis Pharmaceutical Services
• Cytovance Biologics

“*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Service
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Healthcare CMO Market, By Service
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
     • Y-o-Y Growth Analysis (%), 2022 – 2032
     • Segment Trends
   • Medical Device Contract Manufacturing Services
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
   • Pharmaceutical Manufacturing Services
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2022 – 2032
6. Healthcare CMO Market, By Region, 2022 – 2032, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2022 – 2032
     • Y-o-Y Growth Analysis (%), 2022 – 2032
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Service, 2022 – 2032
     • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Service, 2022 – 2032
     • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Service, 2022 – 2032
     • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific

• • Latin America
    • Market Size and Forecast (US$ Mn), By Service, 2022 – 2032
    • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032

 

• • • • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Mn), By Service, 2022 – 2032
    • Market Size and Forecast (US$ Mn), By Country, 2022 – 2032

1. • • • GCC
       • Israel
       • South Africa
       • Rest of Middle East
2. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
3. Company Profiles

• Catalent Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Lonza Group
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Boerhinger Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Patheon Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Accellent Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Emergent Biosolutions Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Greatbatch Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Piramal Healthcare
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Symbiosis Pharmaceutical Services
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cytovance Biologics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. The Last Word
   • Future Impact
   • About Us
   • Contact